26
Sep
2022
Going Upstream Against Inflammation: Samantha Truex on The Long Run
Today’s guest on The Long Run is Samantha Truex. Samantha is the CEO of Waltham, Mass.-based Upstream Bio. Upstream came out of stealth mode with a $200 million Series A financing in June. It’s a big investment in an antibody aimed at the TSLP receptor. It’s a cytokine – an inflammatory protein – that sits at the top of what... Read More